Palestinian International Organization for Peace and Human Rights

August 6, 2026

Cancer treatment crisis in the sector

A human rights report dated August 6, 2026, addressed the crisis of shortages of essential cancer medications in Gaza, noting that approximately eleven thousand cancer patients are facing dire treatment conditions. The shortages include chemotherapy drugs and essential supportive medications necessary for continuing their treatment plans.

Dose interruption and risks of delay

Cancer treatment protocols require precise scheduling of doses, laboratory follow-up, and medical imaging. When a key medication is unavailable or a treatment center is disrupted, the patient’s response may be affected, and it becomes necessary to reassess the treatment plan based on the availability of alternatives.

Additional pressure on families

Patients’ families face additional transportation and care costs, while access to specialist consultations or medical referrals outside the sector is difficult. The challenges are compounded for patients requiring regular follow-up or supportive treatments to alleviate complications.

Right of access to treatment

Ensuring the right to health requires a regular supply of oncology drugs and laboratory supplies, as well as ensuring follow-up care and access to medical evacuation when services are unavailable locally. The crisis necessitates transparent supply plans based on actual treatment needs.

The featured image is for illustrative purposes only and does not document the event itself. It is an archival photograph from Gaza in 2025 and is not a depiction of an oncology department or a specific patient. Photography: Jaber Jihad Badwan, License CC BY-SA 4.0 — Image page.